Cardiovascular Outcomes in High-Risk Patients without Heart Failure Treated with ARBs
- 1 January 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in American Journal of Cardiovascular Drugs
- Vol. 9 (1), 29-43
- https://doi.org/10.1007/bf03256593
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Angiotensin Receptor Blockers May Increase Risk of Myocardial InfarctionCirculation, 2006
- Long-Term and Short-Term Changes in Antihypertensive Prescribing by Office-Based Physicians in the United StatesHypertension, 2006
- Angiotensin receptor blockers and myocardial infarctionBMJ, 2004
- Angiotensin receptor blockers and heart failure: still CHARMing after VALIANT?European Heart Journal, 2004
- Can Angiotensin II Type 2 Receptors Have Deleterious Effects in Cardiovascular Disease?Circulation, 2004
- Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programmeThe Lancet, 2003
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- HEART FAILURE: Angiotensin receptor blockers for chronic heart failure and acute myocardial infarctionHeart, 2001
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)The Lancet, 1997